Stahist Ad Tablet
Product Images NDC 58407-625

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Stahist Ad (NDC 58407-625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Magna Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sample Label

Label for STAHIST AD tablets containing chlorcyclizine hydrochloride 25 mg and pseudoephedrine hydrochloride 60 mg. The label indicates it is a professional sample not for sale, packaged as a 1 count blister card. It includes dosage instructions noting adults and children over 12 years take 1 tablet every 6 hours, not exceeding 3 tablets in 24 hours, with adjusted dosing for children under 12 years.*

FDA Label Image

Principal Display Panel (25 mg/60 mg Tablet Carton)

The image shows the packaging label for Stahist AD tablets containing 25 mg Chlorcyclizine HCl and 60 mg Pseudoephedrine HCl. It is an oral antihistamine and nasal decongestant by Magna Pharmaceuticals, Inc., Louisville, KY, featuring a count of 30 tablets. The label includes dosage instructions and active ingredient details along with storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.